Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults
Abstract Background Gene expression is dysregulated in Alzheimer’s disease (AD) patients, both in peripheral blood and post mortem brain. We investigated peripheral whole-blood gene (co)expression to determine molecular changes prior to symptom onset. Methods RNA was extracted and sequenced for 65 c...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-07-01
|
| Series: | Alzheimer’s Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13195-023-01242-5 |
| _version_ | 1797778993696473088 |
|---|---|
| author | Emma S. Luckett Magdalena Zielonka Amine Kordjani Jolien Schaeverbeke Katarzyna Adamczuk Steffi De Meyer Koen Van Laere Patrick Dupont Isabelle Cleynen Rik Vandenberghe |
| author_facet | Emma S. Luckett Magdalena Zielonka Amine Kordjani Jolien Schaeverbeke Katarzyna Adamczuk Steffi De Meyer Koen Van Laere Patrick Dupont Isabelle Cleynen Rik Vandenberghe |
| author_sort | Emma S. Luckett |
| collection | DOAJ |
| description | Abstract Background Gene expression is dysregulated in Alzheimer’s disease (AD) patients, both in peripheral blood and post mortem brain. We investigated peripheral whole-blood gene (co)expression to determine molecular changes prior to symptom onset. Methods RNA was extracted and sequenced for 65 cognitively healthy F-PACK participants (65 (56–80) years, 34 APOE4 non-carriers, 31 APOE4 carriers), at baseline and follow-up (interval: 5.0 (3.4–8.6) years). Participants received amyloid PET at both time points and amyloid rate of change derived. Accumulators were defined with rate of change ≥ 2.19 Centiloids. We performed differential gene expression and weighted gene co-expression network analysis to identify differentially expressed genes and networks of co-expressed genes, respectively, with respect to traits of interest (APOE4 status, amyloid accumulation (binary/continuous)), and amyloid positivity status, followed by Gene Ontology annotation. Results There were 166 significant differentially expressed genes at follow-up compared to baseline in APOE4 carriers only, whereas 12 significant differentially expressed genes were found only in APOE4 non-carriers, over time. Among the significant genes in APOE4 carriers, several had strong evidence for a pathogenic role in AD based on direct association scores generated from the DISQOVER platform: NGRN, IGF2, GMPR, CLDN5, SMIM24. Top enrichment terms showed upregulated mitochondrial and metabolic pathways, and an exacerbated upregulation of ribosomal pathways in APOE4 carriers compared to non-carriers. Similarly, there were 33 unique significant differentially expressed genes at follow-up compared to baseline in individuals classified as amyloid negative at baseline and positive at follow-up or amyloid positive at both time points and 32 unique significant differentially expressed genes over time in individuals amyloid negative at both time points. Among the significant genes in the first group, the top five with the highest direct association scores were as follows: RPL17-C18orf32, HSP90AA1, MBP, SIRPB1, and GRINA. Top enrichment terms included upregulated metabolism and focal adhesion pathways. Baseline and follow-up gene co-expression networks were separately built. Seventeen baseline co-expression modules were derived, with one significantly negatively associated with amyloid accumulator status (r 2 = − 0.25, p = 0.046). This was enriched for proteasomal protein catabolic process and myeloid cell development. Thirty-two follow-up modules were derived, with two significantly associated with APOE4 status: one downregulated (r 2 = − 0.27, p = 0.035) and one upregulated (r 2 = 0.26, p = 0.039) module. Top enrichment processes for the downregulated module included proteasomal protein catabolic process and myeloid cell homeostasis. Top enrichment processes for the upregulated module included cytoplasmic translation and rRNA processing. Conclusions We show that there are longitudinal gene expression changes that implicate a disrupted immune system, protein removal, and metabolism in cognitively intact individuals who carry APOE4 or who accumulate in cortical amyloid. This provides insight into the pathophysiology of AD, whilst providing novel targets for drug and therapeutic development. |
| first_indexed | 2024-03-12T23:25:25Z |
| format | Article |
| id | doaj.art-a43f03965a3349789f39e38b657efd3e |
| institution | Directory Open Access Journal |
| issn | 1758-9193 |
| language | English |
| last_indexed | 2024-03-12T23:25:25Z |
| publishDate | 2023-07-01 |
| publisher | BMC |
| record_format | Article |
| series | Alzheimer’s Research & Therapy |
| spelling | doaj.art-a43f03965a3349789f39e38b657efd3e2023-07-16T11:11:25ZengBMCAlzheimer’s Research & Therapy1758-91932023-07-0115112310.1186/s13195-023-01242-5Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adultsEmma S. Luckett0Magdalena Zielonka1Amine Kordjani2Jolien Schaeverbeke3Katarzyna Adamczuk4Steffi De Meyer5Koen Van Laere6Patrick Dupont7Isabelle Cleynen8Rik Vandenberghe9Laboratory for Cognitive Neurology, Leuven Brain Institute, KU LeuvenAlzheimer Research Centre KU Leuven, Leuven Brain InstituteLaboratory for Complex Genetics, KU LeuvenLaboratory for Cognitive Neurology, Leuven Brain Institute, KU LeuvenBioClinicaLaboratory for Cognitive Neurology, Leuven Brain Institute, KU LeuvenDivision of Nuclear Medicine, UZ LeuvenLaboratory for Cognitive Neurology, Leuven Brain Institute, KU LeuvenLaboratory for Complex Genetics, KU LeuvenLaboratory for Cognitive Neurology, Leuven Brain Institute, KU LeuvenAbstract Background Gene expression is dysregulated in Alzheimer’s disease (AD) patients, both in peripheral blood and post mortem brain. We investigated peripheral whole-blood gene (co)expression to determine molecular changes prior to symptom onset. Methods RNA was extracted and sequenced for 65 cognitively healthy F-PACK participants (65 (56–80) years, 34 APOE4 non-carriers, 31 APOE4 carriers), at baseline and follow-up (interval: 5.0 (3.4–8.6) years). Participants received amyloid PET at both time points and amyloid rate of change derived. Accumulators were defined with rate of change ≥ 2.19 Centiloids. We performed differential gene expression and weighted gene co-expression network analysis to identify differentially expressed genes and networks of co-expressed genes, respectively, with respect to traits of interest (APOE4 status, amyloid accumulation (binary/continuous)), and amyloid positivity status, followed by Gene Ontology annotation. Results There were 166 significant differentially expressed genes at follow-up compared to baseline in APOE4 carriers only, whereas 12 significant differentially expressed genes were found only in APOE4 non-carriers, over time. Among the significant genes in APOE4 carriers, several had strong evidence for a pathogenic role in AD based on direct association scores generated from the DISQOVER platform: NGRN, IGF2, GMPR, CLDN5, SMIM24. Top enrichment terms showed upregulated mitochondrial and metabolic pathways, and an exacerbated upregulation of ribosomal pathways in APOE4 carriers compared to non-carriers. Similarly, there were 33 unique significant differentially expressed genes at follow-up compared to baseline in individuals classified as amyloid negative at baseline and positive at follow-up or amyloid positive at both time points and 32 unique significant differentially expressed genes over time in individuals amyloid negative at both time points. Among the significant genes in the first group, the top five with the highest direct association scores were as follows: RPL17-C18orf32, HSP90AA1, MBP, SIRPB1, and GRINA. Top enrichment terms included upregulated metabolism and focal adhesion pathways. Baseline and follow-up gene co-expression networks were separately built. Seventeen baseline co-expression modules were derived, with one significantly negatively associated with amyloid accumulator status (r 2 = − 0.25, p = 0.046). This was enriched for proteasomal protein catabolic process and myeloid cell development. Thirty-two follow-up modules were derived, with two significantly associated with APOE4 status: one downregulated (r 2 = − 0.27, p = 0.035) and one upregulated (r 2 = 0.26, p = 0.039) module. Top enrichment processes for the downregulated module included proteasomal protein catabolic process and myeloid cell homeostasis. Top enrichment processes for the upregulated module included cytoplasmic translation and rRNA processing. Conclusions We show that there are longitudinal gene expression changes that implicate a disrupted immune system, protein removal, and metabolism in cognitively intact individuals who carry APOE4 or who accumulate in cortical amyloid. This provides insight into the pathophysiology of AD, whilst providing novel targets for drug and therapeutic development.https://doi.org/10.1186/s13195-023-01242-5Alzheimer’s diseaseRNA sequencingBloodTranscriptomeLongitudinal studyAmyloid accumulation |
| spellingShingle | Emma S. Luckett Magdalena Zielonka Amine Kordjani Jolien Schaeverbeke Katarzyna Adamczuk Steffi De Meyer Koen Van Laere Patrick Dupont Isabelle Cleynen Rik Vandenberghe Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults Alzheimer’s Research & Therapy Alzheimer’s disease RNA sequencing Blood Transcriptome Longitudinal study Amyloid accumulation |
| title | Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults |
| title_full | Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults |
| title_fullStr | Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults |
| title_full_unstemmed | Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults |
| title_short | Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults |
| title_sort | longitudinal apoe4 and amyloid dependent changes in the blood transcriptome in cognitively intact older adults |
| topic | Alzheimer’s disease RNA sequencing Blood Transcriptome Longitudinal study Amyloid accumulation |
| url | https://doi.org/10.1186/s13195-023-01242-5 |
| work_keys_str_mv | AT emmasluckett longitudinalapoe4andamyloiddependentchangesinthebloodtranscriptomeincognitivelyintactolderadults AT magdalenazielonka longitudinalapoe4andamyloiddependentchangesinthebloodtranscriptomeincognitivelyintactolderadults AT aminekordjani longitudinalapoe4andamyloiddependentchangesinthebloodtranscriptomeincognitivelyintactolderadults AT jolienschaeverbeke longitudinalapoe4andamyloiddependentchangesinthebloodtranscriptomeincognitivelyintactolderadults AT katarzynaadamczuk longitudinalapoe4andamyloiddependentchangesinthebloodtranscriptomeincognitivelyintactolderadults AT steffidemeyer longitudinalapoe4andamyloiddependentchangesinthebloodtranscriptomeincognitivelyintactolderadults AT koenvanlaere longitudinalapoe4andamyloiddependentchangesinthebloodtranscriptomeincognitivelyintactolderadults AT patrickdupont longitudinalapoe4andamyloiddependentchangesinthebloodtranscriptomeincognitivelyintactolderadults AT isabellecleynen longitudinalapoe4andamyloiddependentchangesinthebloodtranscriptomeincognitivelyintactolderadults AT rikvandenberghe longitudinalapoe4andamyloiddependentchangesinthebloodtranscriptomeincognitivelyintactolderadults |